Hangzhou Kang Sheng Health Management Consulting, a platform for diabetes management devices, has closed a $100-million series C financing round, 36kr reported.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
